Mahmoud A. Khaimi, MD

Meet your doctor

Mahmoud A. Khaimi, MD is the founder and president of Glaucoma Surgeons of Oklahoma, PLLC. Dr. Khaimi specializes in glaucoma and premium cataract surgery. His passion lies in pioneering and innovating glaucoma surgical procedures and devices, and he is considered a world authority in canaloplasty, a procedure that restores and rejuvenates the natural internal drainage system of the eye. Dr. Khaimi pioneered a huge breakthrough in glaucoma care. In 2013, he developed a minimally invasive glaucoma surgery known as ab-interno canaloplasty (ABiC). The procedure opens up the natural outflow channels of the eye to restore normal aqueous flow without damaging tissue or leaving behind a stent or shunt. Dr. Khaimi performed the first ABiC in 2013 and has since treated patients from all over the world using the procedure. This procedure has been adopted worldwide, and in 2023, Dr. Khaimi was given the great opportunity to pair hand-in-hand with Nova Eye Medical to develop the iTrack™ Advance, designed for improved surgical efficiency. In April 2023, Dr. Khaimi was the first surgeon in the U.S. to perform canaloplasty with the iTrack™ Advance. Subsequently, Dr. Khaimi was awarded 405 magazine’s Healthcare Innovator of the Year in 2023. 

​

Due to his pioneering and innovative breakthroughs in glaucoma surgical procedures and devices, Dr. Khaimi has been active in hosting and teaching numerous surgeons from the United States and internationally in his surgical operating room.  Dr. Khaimi has also traveled throughout the United States and worldwide as a renowned expert speaker and panelist and has performed live surgery internationally. Dr. Khaimi has mentored leading Glaucoma surgeons throughout the USA and worldwide in the art of glaucoma surgical management. One of Dr. Khaimi’s significant accolades is the release of the book, “Essentials of Glaucoma Surgery,” which was published in June 2012 and has been widely distributed. Dr. Khaimi served as associate editor for the text and was also personally involved in the composition of multiple chapters. The book is the first of its kind for glaucoma surgery and provides a window into glaucoma surgical procedures with rapid insight and ready-to-reference information from more than 50 experienced surgeons in the profession. 

​

Dr. Khaimi belongs to the Chandler Grant Society, whose members are focused on preventing blindness from glaucoma by integrating research and clinical disciplines. Certified by the American Board of Ophthalmology, Dr. Khaimi is also a member of the American Glaucoma Society, the American Academy of Ophthalmology, the American Society of Cataract and Refractive Surgery, the European Society of Cataract and Refractive Surgeons, the Oklahoma Academy of Ophthalmology, and the American Medical Association. He also served as vice chair of the Practicing Ophthalmologist Curriculum Committee of the American Academy of Ophthalmology. Dr. Khaimi has served as a delegate to the Michigan Ophthalmological Society and as an American Glaucoma Society Representative for the Advocacy Ambassador Program at the AAO Mid-Year Forum in Washington, D.C. He is also the recipient of the American Glaucoma Society’s Mentoring for Advancement of Physician-Scientists (MAPS) Enabling Award Program.

​

Dr. Khaimi’s effective interest in the development of glaucoma-related surgical innovations and his involvement in numerous clinical trials have allowed him to be active in publishing and presenting his work both nationally and internationally. He was the primary investigator for the Primary Trabeculectomy vs. Tube study, RiGOR study, InnFocus study, and several pharmaceutical research studies. He has been a co-investigator for the Trabeculectomy vs. Tube Study (TVT Study), the Express mini shunt versus Trabeculectomy (XVT) study, the COMPASS study, and the Ologen versus Mitomycin C study. Dr. Khaimi has also coordinated and directed many city-wide glaucoma screenings. He has served as the glaucoma specialist alongside NewView Oklahoma for the annual Macular Degeneration/Low Vision/Glaucoma Seminar in Oklahoma City.

​

In 2017, Dr. Khaimi was honored as “The Journal Record’s” Innovator of the Year. This award recognizes those individuals and organizations that exemplify the innovative spirit in our state. Additionally, Dr. Khaimi has contributed to numerous book chapters, publications, and research in glaucoma and is a scientific reviewer for several ophthalmology journals. Dr. Khaimi has also served on expert panels for the American Glaucoma Society, setting priorities for glaucoma research. Dr. Khaimi has been named to the widely respected Best Doctors in America list, Castle Connelly's "Top Doctors," and was selected as one of America’s Top Ophthalmologists by Guide to America’s Top Ophthalmologists, Consumers’ Research Council of America. He was nominated to serve as a consultant on the Ophthalmic Devices Panel of the Medical Devices Advisory Committee, Center for Devices and Radiological Health, Food, and Drug Administration. Dr. Khaimi is also the lead ophthalmologist for the Oklahoma City Thunder NBA team. Dr. Khaimi’s commitment and dedication to residents’ education led him to be the awardee of the 2010 Excellence in Attending at the Oklahoma City VA Medical Center. As a testament to his dedication to continued education, he has taught ophthalmology residents several cataract and glaucoma surgical courses nationwide.

​​​

A native of Detroit, Michigan, Dr. Khaimi received his undergraduate and medical degrees from Wayne State University, graduating summa cum laude and with honors. He completed an ophthalmology residency at Henry Ford Hospital in Detroit, Michigan. Following his residency, Dr. Khaimi completed a fellowship in glaucoma at the world-renowned Dean McGee Eye Institute/University of Oklahoma Health Sciences Center in Oklahoma City and was asked to stay on the faculty. Dr. Khaimi was a clinical professor at the Dean McGee Eye Institute/University of Oklahoma from 2007 to 2024. During his time at Dean McGee, Dr. Khaimi also held the prestigious James P. Luton, MD Endowed Chair in Ophthalmology Award, and was the Glaucoma Fellowship Director as well as the Director of Glaucoma Services.  In 2024, Dr. Khaimi transitioned to private healthcare and founded Glaucoma Surgeons of Oklahoma (GSO), a center for excellence for the treatment of glaucoma and cataracts. Dr. Khaimi strives to provide the best patient care through advanced surgical techniques and personalized treatment plans, ensuring optimal outcomes and improving the quality of life for each of his patients.